Department of Breast Surgery, Longquanyi District of Chengdu Maternity and Child Health Care Hospital, Chengdu, China.
Department of Orthopaedics, The First People's Hospital of Longquanyi District, Chengdu City, Sichuan, China.
Medicine (Baltimore). 2024 Aug 2;103(31):e39186. doi: 10.1097/MD.0000000000039186.
Primary breast angiosarcoma is a rare tumor, accounting for only 0.05% of all malignant breast tumors. The primary breast angiosarcoma typically presents with nonspecific clinical manifestations, which can easily lead to misdiagnosis. Potential factors contributing to misdiagnosis include skin changes that may be erroneously attributed to breast trauma-induced bruising and breast swelling that may be mistaken for inflammatory diseases or other benign tumors.
A 19-year-old female was admitted to the hospital due to repeated lump formation in the left breast for 9 months after left breast trauma.
The diagnosis of primary breast angiosarcoma was confirmed on hematoma biopsy.
Due to the patient's condition, no special treatment was given postoperatively. After then, there was a recurrence in the chest wall, and the patient received 2 cycles of chemotherapy, resulting in a reduction in the size and lightening of the recurrent chest wall mass. When chemotherapy intolerance happened, the patient chose to discontinue treatment.
After an 18-month follow-up, the recurrent chest wall mass increased and the patient died from bleeding.
Primary breast angiosarcoma has a low incidence but high malignancy, with a high recurrence and metastasis rate, leading to a poor prognosis. The adjuvant chemotherapy, radiotherapy, targeted therapy, and other treatments should be considered to reduce the local recurrence rate and prolong patient survival.
原发性乳腺血管肉瘤是一种罕见的肿瘤,仅占所有恶性乳腺肿瘤的 0.05%。原发性乳腺血管肉瘤的临床表现通常不具特异性,容易导致误诊。导致误诊的潜在因素包括可能被误诊为乳房创伤引起的瘀伤的皮肤改变,以及可能被误诊为炎症性疾病或其他良性肿瘤的乳房肿胀。
一名 19 岁女性因左乳房外伤后 9 个月反复出现左乳房肿块而入院。
血肿活检确诊为原发性乳腺血管肉瘤。
由于患者的病情,术后未给予特殊治疗。随后,胸壁复发,患者接受了 2 个周期的化疗,使复发性胸壁肿块缩小,颜色变浅。当出现化疗不耐受时,患者选择停止治疗。
经过 18 个月的随访,复发性胸壁肿块增大,患者因出血死亡。
原发性乳腺血管肉瘤发病率低,但恶性程度高,复发和转移率高,预后差。应考虑辅助化疗、放疗、靶向治疗等治疗方法,以降低局部复发率,延长患者生存时间。